Asset sale Completed
MERCK KGaA acquisition of JSR Life Sciences chromatography business
Announced Mar 2026 (approx.)
Advisers
JSR Life Sciences chromatography business
Target
Not disclosed
MERCK KGaA
Acquirer
Not disclosed
Other advisers
- Financial adviser
- Target
- JSR Life Sciences chromatography business
- Acquirer
- MERCK KGaA
- Seller
- JSR Life Sciences
- Target based in
- Belgium
- Buyer based in
- Germany
- Seller based in
- Japan (unverified)
- Completed
- Mar 2026
- Sector
- Life Sciences
- Tags
- Life Sciences, Specialty Materials
Similar deals
- Invex Therapeutics acquisition of Rekover Therapeutics Oct 2026 · Healthcare
- Element Biosystems acquisition of Standard BioTools Mass Cytometry business Sep 2026 · US$5.5m · Life Sciences
- Webster Equity Partners acquisition of Lifecore Biomedical Sep 2026 · US$664m · Pharma Services
- TPG acquisition of Agilex Biolabs Sep 2026 · US$114m · Healthcare
- Telix Pharmaceuticals and ITM Isotope Technologies Munich SE merger Sep 2026 · US$2.4bn · Healthcare
Sources
- Mar 2026 William Blair: JSR Life Sciences has sold its chromatography business to MERCK KGaA williamblair.com
